A review of the current nomenclature for psychotropic agents and an introduction to the Neuroscience-based Nomenclature.

Authors :: Zohar J
Stahl S
Moller HJ
Blier P
Kupfer D
Yamawaki S
Uchida H
Spedding M
Goodwin GM
Nutt D
Source :: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology [Eur Neuropsychopharmacol] 2015 Dec; Vol. 25 (12), pp. 2318-25. Date of Electronic Publication: 2015 Sep 07.
Publication Year :: 2015
Abstract: Neuroscience based Nomenclature (NbN) is a new system of classifying psychotropic drugs by their pharmacological profile. The NbN was developed to replace the current indication-based nomenclature and to provide an up-to-date and more useful framework to better inform pharmacological decisions. NbN provides updated relevant and specific scientific, regulatory and clinical information, aiming to support rational and lucid prescribing. This pharmacologically driven nomenclature, which highlights pharmacological domains and modes of action, may also increase drug adherence as it clarifies the rationale for selecting a specific psychotropic agent.<br /> (Copyright © 2015. Published by Elsevier B.V.)

Subjects :: Humans
Neurosciences
Psychotropic Drugs classification
Psychotropic Drugs therapeutic use
Terminology as Topic

Language :: English
ISSN :: 1873-7862
Volume :: 25
Issue :: 12
Database :: MEDLINE
Journal :: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Publication Type :: Academic Journal
Accession number :: 26527055
Full Text :: https://doi.org/10.1016/j.euroneuro.2015.08.019

Full Text Access

Tools